FDA approves new injectable drug for schizophrenia
On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read more
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.